Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
J. Schmitt, Eckart Meese(Saarland University), Andreas Keller(Helmholtz Institute for Pharmaceutical Research Saarland), Norbert Graf(Saarland University), Nicole Ludwig(Saarland University), Nasenien Nourkami‐Tutdibi(Saarland University), Petra Leidinger(Saarland University), Nunja Habel(Saarland University), Manfred Gessler(Comprehensive Cancer Center Mainfranken), Hans‐Peter Lenhof(Saarland University), Frank Berthold(University of Cologne), Sabrina Heisel
Cited by 9
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
|Nature Methods|2017|1.3k
Distribution of miRNA expression across human tissues
|Nucleic Acids Research|2016|1k
The Notch target genes <i>Hey1</i> and <i>Hey2</i> are required for embryonic vascular development
|Genes & Development|2004|650